CN Stock MarketDetailed Quotes

688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist

50.02
-1.46-2.84%

Market Closed Jan 15 15:00 CST

10.99BMarket Cap26.08P/E (TTM)

Jiangsu Sinopep-Allsino Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.382B	--
--	2024/FY	-- / 1.774B	--
Mar 29, 2024	2023/FY	1.036B / 950.510M	--
--	2022/FY	651.292M / 659.000M	--
--	2021/FY	641.869M / 642.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.382B--

--2024/FY-- / 1.774B--

Mar 29, 20242023/FY1.036B / 950.510M--

--2022/FY651.292M / 659.000M--

--2021/FY641.869M / 642.000M--

Unlock Free Earnings Estimates

Open Account

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Reports

Nootech: Third quarter report 2024

Oct 22, 2024 12:00 ET

NOTEC Biotech: NOTEC Biotech: Voluntary Disclosure Notice for the Third Quarter of 2024 Results Forecast

Oct 7, 2024 12:00 ET

Nootech: Voluntary Disclosure Notice for the Third Quarter of 2024 Earnings Forecast

Oct 7, 2024 12:00 ET

Jiangsu Sinopep-Allsino Biopharmaceutical: Summary of Half-Year Report in 2024.

Aug 22, 2024 12:00 ET

Analyst Rating

Updated: Jan 15, 2025

Strong Buy

Strong Buy
90.91%
Buy
9.09%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Includes Convertible Bonds

Intraday-0.33%

ShangHai Stock Connect

Intraday-0.37%

Finance and Securities Lending

Intraday-0.49%